The agency is anticipating a "very healthy" 2013 in its pharmaceutical division, according to director of business development Hannah Wilkinson.
"We have been working in the pharmaceutical sector for many years but it has boosted us even further," explained Wilkinson. "We are predicting an uplift of ten per cent in turnover and profit on our pharma division and next year is looking very healthy in that sector."
Zibrant is working with a pharma client in Cambridge, for which the agency has placed an implant member of staff, as well as clients headquartered in Copenhagen and Zurich.
Some members of Zibrant’s Derby operation have moved to its Canterbury base, to help service the clients.
Wilkinson added the work included a project in the Middle East in April for 550 people.